Arthrex receives FDA clearance for pediatric indication of ACL implant
Click Here to Manage Email Alerts
Arthrex Inc. has announced FDA clearance of its TightRope implant for use in pediatric patients with ACL injuries, according to a company press release.
“For more than a decade, Arthrex has worked closely with leading orthopedic surgeons from Hospital for Special Surgery (HSS) to develop minimally invasive solutions for pediatric and young adolescent ACL surgery,” Reinhold Schmieding, president and founder of Arthrex, said in the release. “We are proud to partner with surgeons from HSS to design treatment options specifically for ACL injuries in younger patients. This is a significant achievement in orthopedic surgery and another testament to Arthrex’s dedication to its mission of helping surgeons treat their patients better, starting from an early age,” Schmieding added.
Read more about
Click Here to Manage Email Alerts